CSIRO promises review after profiting from diet pill that was not 'clinically validated'

Federal science agency says the use of its name is ‘outside the scope’ of agreement with Probiotec

Federal science agency the CSIRO is reviewing its links to a diet pill after it emerged it was profiting from the sales of a product that is not medically proven.

Blackmores is selling the Metabolic C12 supplement, under the umbrella of Impromy – a weight loss program the CSIRO developed.

Continue reading...

from The Guardian https://ift.tt/2YdwKsM
via
0 Comments